| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | +101.2% |
| R&D Expense | $6.0M | +44.3% |
| SG&A Expense | $4.7M | +43.6% |
| Operating Income | -$17.1M | -94.0% |
| Net Income | -$19.8M | -229.2% |
| EPS (Basic) | -$0.66 | +57.1% |
| EPS (Diluted) | -$0.66 | +57.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.5M | +92.6% |
| Accounts Receivable | $2K | -96.4% |
| Inventory | $615K | +3.9% |
| Current Assets | $12.4M | +81.6% |
| Total Assets | $18.7M | +45.4% |
| Current Liabilities | $5.0M | +63.0% |
| Total Liabilities | $14.1M | -10.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | -11.7% |
| Capital Expenditures | $169K | -39.6% |
| Investing Cash Flow | -$265K | +12.0% |
| Financing Cash Flow | $16.3M | +5.1% |
| Free Cash Flow | -$10.7M | -10.2% |
| Stockholders' Equity |
| $4.6M |
| +261.8% |